tirzepatide vs. semaglutide vs Trial Results Post from Cleveland Clinic -

Retatrutide is the developmental designation for an investigational compound owned by Eli Lilly and Company

Semaglutide supplemented with B12 offers a modern approach to chronic weight management, especially for individuals facing an obesity related health condition or struggling with excess weight

This treatment increases cellular turnover, assists with the release of comedones, decreases fine lines and wrinkles, evens skin tone and texture, and stimulates the production of collagen and elastin

Activation of these sensors initiates checkpoint cascades, most notably ATMChk2 and ATRChk1, which coordinate cell cycle arrest, DNA repair pathway selection and apoptosis or senescence when repair fails

Early studies suggest semaglutide may help with PMOS-related symptoms like insulin resistance and body size, as well as BMI and waist circumference

T.VenketaramanV